Navigation Links
Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
Date:10/29/2009

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's Web site: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure and integrate new products for commercialization and/or development; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's products; the Company's ability to register, maintain and enforce patents and other intelle
'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
2. Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA
3. Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
4. Veriscrip and DAMMAD Team Up to Combat Prescription Drug Abuse in New Hampshire
5. New Hampshire Rx Card Launching Statewide
6. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
7. Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
8. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
9. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced data ... in a Phase 1 investigator-sponsored study at the University ... presented at the 2015 American Society of Clinical Oncology ... Results from this study show a tolerable safety ... given intravenously.  Based in part on the ...
(Date:6/1/2015)... PARK, Calif. , June 1, 2015 ... device company that is providing innovative evidence-based solutions for ... has commenced an underwritten public offering of its common ... Nevro and 2,459,175 shares to be sold by certain ... the underwriters a 30-day option to purchase up to ...
(Date:6/1/2015)... Eastern MRI systems market is fast growing. MRI being a ... medicine like cardiology, neurology and orthopedics. It is replacing older ... as safer tool as it does not use ionizing radiations. ... Open system, closed system and straight or upright system. The ... is preferred over that currently common closed type as it ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 3
... researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) ... important brain signaling pathways. The study raises the ... offer a new treatment option for patients with ... million U.S. children. "At least 10 ...
... Dec. 2, 2011  MedinCell, a leading developer of ... partnerships for key companion and food animal markets ... Health Congress in Kansas City (December 6-8, 2011). ... control over the duration of drug release, thereby ...
Cached Medicine Technology:New Gene Study of ADHD Points to Defects in Brain Signaling Pathways 2New Gene Study of ADHD Points to Defects in Brain Signaling Pathways 3New Gene Study of ADHD Points to Defects in Brain Signaling Pathways 4MedinCell to Explore Controlled-Release Drug Delivery Partnerships at the World Animal Health Congress 2
(Date:6/1/2015)... Sharenote, a leading web-base electronic healthcare software (EHR) is ... in Louisiana. The entrepreneurial trio behind Sharenote, will travel ... providers with the tools and resources to monitor key ... network. , Find out why Sharenote is the ... than 250 practices. , Four Day Schedule ...
(Date:6/1/2015)... There’s never a good time to be sick and need ... , As of June 1, OSF HealthCare is offering ... the Internet. Patients throughout Illinois can access care whenever they ... busy. We know that getting in to see a provider ... it easier,” said Jeffry Tillery, MD, Chief Transformation Officer for ...
(Date:6/1/2015)... Hexagon Geospatial is pleased to announce the launch ... service that provides on-demand access to the company’s world-class ... IMAGINE and GeoMedia are now available ... subscription model for delivering software products as an online ... quickly and easily access the right tools that help ...
(Date:6/1/2015)... June 01, 2015 Good360 announced ... the Irene W. and C.B. Pennington Foundation, Louisiana’s ... board of directors. Bertman joins Good360 just before ... this summer. , "Bringing with her many years ... am thrilled that Lori is joining the Good360 ...
(Date:6/1/2015)... Triple C announced today that they will be ... this year on RFD-TV. , From the humble, farm shop ... the today’s full line of rugged products, Triple C, Inc. ... , In this segment, American Farmer will explore how ... thrive in the tough conditions on North American ranches. Viewers ...
Breaking Medicine News(10 mins):Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3Health News:Lori Bertman Joins Good360 Board of Directors 2Health News:Triple C to Be Featured in Upcoming Episode of American Farmer 2
... non-serious side effects , , FRIDAY June 27 (HealthDay News) ... marijuana plant don,t increase the risk of serious side ... non-serious side effects, Canadian scientists report. , The researchers ... British Columbia (UBC) examined adverse events reported in 31 ...
... (PTCB), the leading national program that has ... and congratulates the Florida House of Representatives ... requiring new standards for pharmacy technicians. The ... toward increasing patient safety for consumers. The ...
... /PRNewswire-FirstCall/,-- Schering-Plough Corp. (NYSE: SGP ) and ... the withdrawal of the New Drug Application (NDA) ... terminated the Schering-Plough/Merck Pharmaceuticals,respiratory joint venture, which was ... fixed-combination product that would combine loratadine and,montelukast. This ...
... 27 Health care facilities,in the U.S. are ... infections (HAI). Could there be hidden areas of,infection ... education program,from the production company Mission Critical attempts ... Areas of Infection,",( http://www.missioncriticaltv.com/index-8-1.html ) documents how an ...
... to the latest,report by the American Lung Association, Lung ... increasing while death rates due to other,leading causes of ... Chronic obstructive pulmonary disease (COPD) is expected to,become the ... American Lung Association publishes Lung Disease Data to serve ...
... a World Health Organization expert on E. coli ... Bioniche Life Sciences,Inc. (TSX: BNC), a research-based, technology-driven ... this week,entitled, "E. coli O157 Vaccine: Added Value ... from the food industry: Beef,dairy, and other agricultural ...
Cached Medicine News:Health News:Drugs With Marijuana Compounds Don't Boost Adverse Events 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 3Health News:Hidden Areas of Infection in U.S. Hospitals 2Health News:Hidden Areas of Infection in U.S. Hospitals 3Health News:American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing 2Health News:American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing 3Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 2Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 3Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 4Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 5
... Accurate Quantitation of DNA, RNA, Or Fluorescent ... and RNA is critical to life science research. ... way to measure quantities as small as 1ng/ml ... another set of excitation and emission filters, the ...
The Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies, providing a full coverage for fluorometric, glow and flash luminometric applications even in the...
... DyNA Quant™ 200 is a ... excitation and 460 nm emission. The ... the detection of double-stranded DNA using ... assay, which minimizes interference from the ...
... is a multifunctional single ... give you utmost flexibility ... and absorbance. Modulus operates ... dedicated luminometer, or a ...
Medicine Products: